408 related articles for article (PubMed ID: 32398133)
21. Cathepsin S Knockdown Suppresses Endothelial Inflammation, Angiogenesis, and Complement Protein Activity under Hyperglycemic Conditions In Vitro by Inhibiting NF-κB Signaling.
Sayed S; Faruq O; Preya UH; Kim JT
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982499
[TBL] [Abstract][Full Text] [Related]
22. Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.
Chen SJ; Chen LH; Yeh YM; Lin CK; Lin PC; Huang HW; Shen MR; Lin BW; Lee JC; Lee CC; Lee YF; Chiang HC; Chang JY
Theranostics; 2021; 11(10):4672-4687. PubMed ID: 33754020
[No Abstract] [Full Text] [Related]
23. Rational design of humanized antibody inhibitors for cathepsin S.
Yu PW; Kao G; Dai Z; Nasertorabi F; Zhang Y
Arch Biochem Biophys; 2024 Jan; 751():109849. PubMed ID: 38061628
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin S is a novel target for age-related dry eye.
Yu Z; Li J; Govindarajan G; Hamm-Alvarez SF; Alam J; Li DQ; de Paiva CS
Exp Eye Res; 2022 Jan; 214():108895. PubMed ID: 34910926
[TBL] [Abstract][Full Text] [Related]
25. Decreased serum cathepsin S levels in patients with systemic sclerosis-associated interstitial lung disease.
Toyama S; Yamashita T; Saigusa R; Miura S; Nakamura K; Hirabayashi M; Miyagawa T; Fukui Y; Omatsu J; Yoshizaki A; Sato S; Asano Y
J Dermatol; 2020 Sep; 47(9):1027-1032. PubMed ID: 32515028
[TBL] [Abstract][Full Text] [Related]
26. Nicotine Modulates CTSS (Cathepsin S) Synthesis and Secretion Through Regulating the Autophagy-Lysosomal Machinery in Atherosclerosis.
Ni H; Xu S; Chen H; Dai Q
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2054-2069. PubMed ID: 32640907
[TBL] [Abstract][Full Text] [Related]
27. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
Brassington K; Selemidis S; Bozinovski S; Vlahos R
Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis.
Gautam J; Banskota S; Lee H; Lee YJ; Jeon YH; Kim JA; Jeong BS
Exp Mol Med; 2018 Sep; 50(9):1-14. PubMed ID: 30185799
[TBL] [Abstract][Full Text] [Related]
29. Cathepsin S activity controls chronic stress-induced muscle atrophy and dysfunction in mice.
Wan Y; Piao L; Xu S; Meng X; Huang Z; Inoue A; Wang H; Yue X; Jin X; Nan Y; Shi GP; Murohara T; Umegaki H; Kuzuya M; Cheng XW
Cell Mol Life Sci; 2023 Aug; 80(9):254. PubMed ID: 37589754
[TBL] [Abstract][Full Text] [Related]
30. Phenylephrine increases tear cathepsin S secretion in healthy murine lacrimal gland acinar cells through an alternative secretory pathway.
Fu R; Janga S; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2021 Oct; 211():108760. PubMed ID: 34487726
[TBL] [Abstract][Full Text] [Related]
31. Cathepsin S regulates renal fibrosis in mouse models of mild and severe hydronephrosis.
Yao X; Cheng F; Yu W; Rao T; Li W; Zhao S; Zhou X; Ning J
Mol Med Rep; 2019 Jul; 20(1):141-150. PubMed ID: 31115520
[TBL] [Abstract][Full Text] [Related]
32. Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis.
Johnson EM; Doyle JD; Wetzel JD; McClung RP; Katunuma N; Chappell JD; Washington MK; Dermody TS
J Virol; 2009 Oct; 83(19):9630-40. PubMed ID: 19640986
[TBL] [Abstract][Full Text] [Related]
33. Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation.
Kim S; Jin H; Seo HR; Lee HJ; Lee YS
Cell Death Differ; 2019 May; 26(5):812-825. PubMed ID: 30006610
[TBL] [Abstract][Full Text] [Related]
34. Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice.
Tjondrokoesoemo A; Schips TG; Sargent MA; Vanhoutte D; Kanisicak O; Prasad V; Lin SC; Maillet M; Molkentin JD
J Biol Chem; 2016 May; 291(19):9920-8. PubMed ID: 26966179
[TBL] [Abstract][Full Text] [Related]
35. PU.1 regulates cathepsin S expression in professional APCs.
Wang Y; Baron RM; Zhu G; Joo M; Christman JW; Silverman ES; Perrella MA; Riese RJ; Cernadas M
J Immunol; 2006 Jan; 176(1):275-83. PubMed ID: 16365419
[TBL] [Abstract][Full Text] [Related]
36. Cathepsin S deficiency improves muscle mass loss and dysfunction via the modulation of protein metabolism in mice under pathological stress conditions.
Wan Y; Piao L; Xu S; Inoue A; Meng X; Lei Y; Huang Z; Wang H; Yue X; Shi GP; Kuzuya M; Cheng XW
FASEB J; 2023 Aug; 37(8):e23086. PubMed ID: 37428652
[TBL] [Abstract][Full Text] [Related]
37. Cathepsin S, a new serum biomarker of sarcoidosis discovered by transcriptome analysis of alveolar macrophages.
Tanaka H; Yamaguchi E; Asai N; Yokoi T; Nishimura M; Nakao H; Yoneda M; Ohtsuka Y; Konno S; Yamada N
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(2):141-147. PubMed ID: 32476947
[TBL] [Abstract][Full Text] [Related]
38. Emerging role of cathepsin S in obesity and its associated diseases.
Taleb S; Clément K
Clin Chem Lab Med; 2007; 45(3):328-32. PubMed ID: 17378727
[TBL] [Abstract][Full Text] [Related]
39. Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.
Meng Z; Edman MC; Hsueh PY; Chen CY; Klinngam W; Tolmachova T; Okamoto CT; Hamm-Alvarez SF
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C942-54. PubMed ID: 27076615
[TBL] [Abstract][Full Text] [Related]
40. Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women.
Taleb S; Cancello R; Poitou C; Rouault C; Sellam P; Levy P; Bouillot JL; Coussieu C; Basdevant A; Guerre-Millo M; Lacasa D; Clement K
J Clin Endocrinol Metab; 2006 Mar; 91(3):1042-7. PubMed ID: 16394095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
